| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2125093 | European Journal of Cancer | 2010 | 10 Pages |
Abstract
The strategy of chemotherapy did not influence the deterioration of QoL. The TUDD approach seems to provide meaningful clinical results that are adapted to metastatic pancreatic adenocarcinoma trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Franck Bonnetain, Laetitia Dahan, Emilie Maillard, Marc Ychou, Emmanuel Mitry, Pascal Hammel, Jean-Louis Legoux, Philippe Rougier, Laurent Bedenne, Jean-François Seitz,